Official AMFI data
Arthkar
Baroda BNP Paribas

Baroda BNP Paribas Health and Wellness Fund Direct Growth

Sectoral / ThematicEquity SEBI-regulated

NAV (Direct-Growth)

₹10.4118

As of 1 Jul 2026 · AMFI

AUM

₹515.19 Cr

Expense ratio

0.60%

1Y returns

cat 3.20%

3Y CAGR

cat 23.13%

5Y CAGR

cat 13.73%

Std deviation 3Y

cat 16.46%

In plain English

Baroda BNP Paribas Health and Wellness Fund Direct Growth is a Sectoral / Thematic scheme from Baroda BNP Paribas. The portfolio is ~96% in equities. Worst historical drawdown: -11% in Jan 2026, recovered in 4 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

NAV (Direct-Growth)

₹10.4118

Last 1Y

+3.99%

Jul 25Min ₹9.06 · Max ₹10.45 · 245 ptsJul 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Jan 2026

-11.1%

Peak ₹10.19 on 30 Jul 2025 → trough ₹9.06 on 29 Jan 2026 (6 months down).

Recovered in 4 months· 19 May 2026

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.60% — well below typical 1% for equity.

  • AUM size

    ₹515 Cr.

  • Sector concentration

    Top 3 sectors = 95.9% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+1.41%+0.29%15/ 18
1M+2.75%+3.93%17/ 18
3M+4.98%+5.61%17/ 18
6M-2.08%-1.63%15/ 17
YTD+0.55%+0.18%14/ 18
1Y+3.20%
2Y+12.10%
3Y+23.13%
5Y+13.73%
7Y+19.14%
10Y+13.62%

Portfolio composition

Asset allocation

  • Equity95.92%
  • Cash4.08%

By market cap

  • Large cap29.18%
  • Mid cap32.43%
  • Small cap29.64%
  • Others8.75%

Concentration

Holdings

34

Avg market cap

₹60.2K Cr

Top 10 stocks

52.23%

Top 5 stocks

32.66%

Top 3 sectors

95.92%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 1

    Sun Pharmaceuticals Industries Ltd

    10.23%
  • 2

    Lupin Ltd

    6.29%
  • 3

    Abbott India Ltd

    5.53%
  • 4

    Torrent Pharmaceuticals Ltd

    5.32%
  • 5

    Ipca Laboratories Ltd

    5.28%
  • 6

    Clearing Corporation Of India Ltd

    4.52%
  • 7

    Laurus Labs Ltd

    4.43%
  • 8

    J.B. Chemicals & Pharmaceuticals Ltd

    4.41%
  • 9

    AstraZeneca Pharma India Ltd

    3.92%
  • 10

    SBI Life Insurance Co Ltd

    3.45%
  • 11

    Emcure Pharmaceuticals Ltd

    3.36%
  • 12

    Aster DM Healthcare Ltd Ordinary Shares

    3.25%
  • 13

    Apollo Hospitals Enterprise Ltd

    3.24%
  • 14

    Fortis Healthcare Ltd

    3.09%
  • 15

    Gland Pharma Ltd

    2.96%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio40.9239.01+1.91
  • P/B ratio6.565.58+0.98
  • Price / Sales4.505.22-0.72
  • Price / Cash Flow30.9328.70+2.23
  • Dividend yield0.73%0.67%+0.06
  • Return on equity (ROE)0.00%

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    12.6216.4615.45
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    -0.230.960.61
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    -0.291.701.00
  • Beta

    1 = moves with the market. <1 = less volatile.

    0.930.950.92

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN
  • DirectGrowthBaroda BNP Paribas Health and Wellness Fund Direct GrowthINF251K01VA5